Foutch Brian K, Sandberg Kyle A, Bennett Edward S, Naeger Leonard L
Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, TX 78229, USA.
College of Optometry, University of Missouri-St Louis, St. Louis, MO 63121, USA.
Vision (Basel). 2020 Jun 20;4(2):32. doi: 10.3390/vision4020032.
The goal of this study was to investigate the effects of two commonly used oral antihistamines-diphenhydramine and loratadine-on tear volume, tear breakup time, and intraocular pressure. Placebo, diphenhydramine, and loratadine were administered for one week to 33 subjects experimentally blind to the treatment given. All the subjects received all three treatments over a period of six weeks. The outcome measures were the change in phenol red thread test (PRT), the tear breakup time (TBUT), and the intraocular pressure (IOP) of both eyes evaluated by experimentally masked observers. Neither of the mean changes in TBUT or IOP depended on the treatment given, but there was a significant monocular decrease in tear volume from diphenhydramine use. While we used an adequate treatment washout period of seven days, our investigation was limited by the short treatment times and inclusion of only young healthy patients. Overall, however, these results suggest that systemic diphenhydramine use should be limited to increase the effectiveness of conventional therapies. Clinicians should have fewer reservations about recommending the use of loratadine concurrent with dry eye treatments.
本研究的目的是调查两种常用口服抗组胺药——苯海拉明和氯雷他定——对泪液量、泪膜破裂时间和眼压的影响。对33名对所给予治疗不知情的受试者给予安慰剂、苯海拉明和氯雷他定,为期一周。所有受试者在六周内接受了所有三种治疗。观察指标为通过不知情的观察者评估的酚红棉线试验(PRT)、泪膜破裂时间(TBUT)和双眼眼压(IOP)的变化。TBUT或IOP的平均变化均不取决于所给予的治疗,但使用苯海拉明后泪液量出现了显著的单眼减少。虽然我们采用了七天的充分治疗洗脱期,但我们的研究受到治疗时间短和仅纳入年轻健康患者的限制。然而,总体而言,这些结果表明,应限制全身性使用苯海拉明以提高传统疗法的疗效。临床医生在推荐氯雷他定与干眼治疗同时使用时应减少顾虑。